Gap junction remodelling by chronic pressure overload is related to the increased susceptibility to atrial fibrillation in rat heart

Europace

Volumn 17, Issue 4, 2015, Pages 655-663

  Shin, Seung Yong ^a   Jo, Won Min ^b   Min, Too Jae ^b   Kim, Byoung Kwon ^c   Song, Dae Hyun ^d   Hyeon, Seong Hyeop ^a   Kwon, Jee Eun ^a   Lee, Wang Soo ^a   Lee, Kwang Je ^a   Kim, Sang Wook ^a   Kim, Tae Ho ^a   Kim, Chee Jeong ^a   Im, Sung Il ^e   Lim, Hong Euy ^e  

^a Chung Ang University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Department of Thoracic Surgery Armed Forces Capital Hospital   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

Atrial fibrillation; Connexin; Fibroblast; Fibrosis; Gap junction; Hypertrophy; Pressure overload; Remodelling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNEXIN 43; GAP JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE PREDISPOSITION; DOWN REGULATION; GAP JUNCTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM HYPERTROPHY; HEART HEMODYNAMICS; HEART LEFT ATRIUM HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART PACING; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; ISCHEMIC CARDIOMYOPATHY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; SYSTOLIC DYSFUNCTION; ANIMAL; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIOMYOPATHY; CHRONIC DISEASE; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIOMYOPATHIES; CHRONIC DISEASE; CONNEXINS; DISEASE SUSCEPTIBILITY; GAP JUNCTIONS; HYPERTROPHY, LEFT VENTRICULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84926653460     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu294     Document Type: Article

References (28)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A et al. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 2009;119:606-18.
2. Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol 2013;167: 2412-20.
3. Kosiuk J, Breithardt O, Bode K, Kornej J, Arya A, Gaspar T et al. Left ventricular diastolic dysfunction and thromboembolic risk in atrial fibrillation: diastolic dysfunction and thromboembolic risk in AF. Int J Cardiol 2013;168:547-8.
4. Melduni RM, Suri RM, Seward JB, Bailey KR, AmmashNM, Oh JK et al. Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-operative atrial fibrillation. J Am Coll Cardiol 2011;58:953-61.
5. Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ. Echocardiographic diastolic parameters and risk of atrial fibrillation: the CardiovascularHealth Study. Eur Heart J 2012;33:904-12.
6. Rosenberg MA, Manning WJ. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal. Circulation 2012;126:2353-62.
7. Kim SJ, Choisy SC, Barman P, Zhang H, Hancox JC, Jones SA et al. Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload. Circ Arrhythm Electrophysiol 2011;4:761-9.
8. Kume O, Takahashi N, Wakisaka O, Nagano-Torigoe Y, Teshima Y, Nakagawa M et al. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm 2011;8:278-85.
9. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y et al. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 2010;120:242-53.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from theAmerican Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
11. AkkayaM, Higuchi K,Koopmann M, Burgon N, Erdogan E, Damal Ket al. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace 2013;15:1725-32.
12. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72:69-79.
13. Zhang P,WangW,Wang X, Song Y, Zhang J, Zhao H. Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease. Int J Cardiol 2013;168:3200-7.
14. Fukui A, Takahashi N, Nakada C, Masaki T, Kume O, Shinohara T et al. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ Arrhythm Electrophysiol 2013;6:402-9.
15. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011;89: 744-53.
16. Goudis CA, Kallergis EM, Vardas PE. Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace 2012; 14:623-30.
17. Rohr S. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm 2009;6:848-56.
18. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 2007;101:755-8.
19. Musa H, Kaur K, O'Connell R, Klos M, Guerrero-Serna G,AvulaUMet al. Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts. Heart Rhythm 2013;10: 1044-51.
20. van der VeldenHM,Ausma J, RookMB, Hellemons AJ, van VeenTA, AllessieMAet al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000;46:476-86.
21. Bikou O, Thomas D, Trappe K, Lugenbiel P, Kelemen K, Koch M et al. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovasc Res 2011;92:218-25.
22. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID et al. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation 2012;125:216-25.
23. Hsieh MH, Lin YJ,Wang HH, Lo LW, Chang SL, Yan YL et al. Functional characterization of atrial electrograms in a pacing-induced heart failure model of atrial fibrillation: importance of regional atrial connexin40 remodeling. J Cardiovasc Electrophysiol 2013;24:573-82.
24. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006;354: 2677-88.
25. Juang JM, Chern YR, Tsai CT, Chiang FT, Lin JL, Hwang JJ et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007;116:107-12.
26. Wirka RC, Gore S, Van Wagoner DR, Arking DE, Lubitz SA, Lunetta KL et al. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:87-93.
27. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999;99:1508-15.
28. Laurent G, Leong-Poi H, Mangat I, Moe GW, Hu X, So PP et al. Effects of chronic gapjunctionconduction-enhancing antiarrhythmicpeptideGAP-134administrationon experimental atrial fibrillation in dogs. Circ Arrhythm Electrophysiol 2009;2:171-8.